Public Health - Drug Manufacturer-Funded Disease Awareness Campaigns - Registration and Required Disclosure
In the House - Hearing 3/12 at 1:00 p.m.
Summary
The bill forces drug manufacturers and any patient advocacy organization that receives their funding to file a registration with the Maryland Department of Health before launching a disease‑awareness effort. Campaign materials must clearly state the specific drug or device being marketed for the condition featured. This aims to increase transparency for the public about commercial influences behind health information.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 1133 changes status, plus AI-powered summaries and stage predictions.
Sign up free